Whole Body Cryotherapy
In 1978 Dr. Toshiro Yamauchi of Oita, Japan was the first person in the world to make use extremely cold temperatures in treating Rheumatoid Arthritis. Since then, research on the use of Whole Body Cryotherapy (WBC) has been primarily conducted in Europe. Most published research has been conducted using closed engineering systems in which the whole body, including the head, is within the chamber. It is our goal to add to the body of knowledge by conducting research in collaboration with local, national, and international research institutions.
Entering the Cryo-Chamber
What are the risks?
Wholebody Cryotherapy is very well tolerated and has minimal risks: there may be fluctuations in systolic blood pressure during the procedure by up to 10 points (this effect reverses after the end of the procedure, as peripheral circulation returns to normal), allergic reaction to extreme cold (rare), redness, and skin irritations, (only if exposed to low temperatures longer than recommended or having an unusual cold sensitivity).
Note: Skin irritations, if they occur, are temporary and are an indication that the user should wear additional clothing covering the affected area on future visits. Should this occur, talk to your Primary Health Care Provider.